KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Research & Development: 2009-2025

Historic Research & Development for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $166.0 million.

  • Bausch Health Companies' Research & Development rose 13.70% to $166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $631.0 million, marking a year-over-year increase of 4.30%. This contributed to the annual value of $616.0 million for FY2024, which is 1.99% up from last year.
  • Per Bausch Health Companies' latest filing, its Research & Development stood at $166.0 million for Q3 2025, which was up 4.40% from $159.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Research & Development ranged from a high of $166.0 million in Q3 2025 and a low of $112.0 million during Q1 2021.
  • In the last 3 years, Bausch Health Companies' Research & Development had a median value of $153.0 million in 2023 and averaged $153.5 million.
  • Its Research & Development has fluctuated over the past 5 years, first dropped by 8.20% in 2021, then increased by 22.83% in 2023.
  • Bausch Health Companies' Research & Development (Quarterly) stood at $117.0 million in 2021, then increased by 21.37% to $142.0 million in 2022, then increased by 7.04% to $152.0 million in 2023, then climbed by 7.24% to $163.0 million in 2024, then grew by 13.70% to $166.0 million in 2025.
  • Its last three reported values are $166.0 million in Q3 2025, $159.0 million for Q2 2025, and $143.0 million during Q1 2025.